On the recordFebruary 10, 2015
Thank you, Mr. Rohrabacher. I know in your district--in the Orange County area--there is major medical research going on at the University of California at Irvine and, certainly, at UCLA, at the mind institutes there. Out of that research do come new technologies, new drugs, new kinds of equipment, some of which are patentable; and the licensing of the new drugs through the FDA is always a challenge, so we do have multiple tasks here. We have to deal with the patent laws and the availability of patent research dollars and then have to make sure that the drug actually is made available to address the illness. I thank you so very much for joining us. Mr. Speaker, I want to go back to a couple of things that we were talking about earlier on the research side. Our goal is to ramp up this research to try to get to the level that is suggested. Now, we always look at cost benefit. Is this research going to pay off? I think it will. As I was preparing for this evening, I came across an email, actually, from the University of California at Davis, which I represent--near Sacramento--at their California National Primate Research Center. They have been using stem cell research to address the issue of Alzheimer's. What they have found is that they are able to use this Nouvelle stem cell therapy in primates, which is similar to the human brain, and to actually have some success. They have now taken it the next step further. Here is where we are into the FDA and the approval of drugs, Mr.…
Source
govinfo.gov




